Enter your terms above and click the 'Search' button.

Showing articles 0 to 12 of 12 Filter Applied: melanoma,malignant (Click to remove) Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Intracerebral and Subarachnoid Hemorrhage in Patients with Cancer Neurol 74:494-501, Navi,B.B.,et al, 2010 Evaluation of Exophthalmos NEJM 292:1005-1013, Grove,A.S., 1975 Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study Arch Neurol 30:122, Olson,M.E.,et al, 1974 Case Report: Cutaneous Metastasis of Adenocarcinoma Pract Derm, 28-31, Sickles,C.,et al, 2018 Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016 Neurological Immune-Related Adverse Events of Ipilimumab Pract Neurol 13:278-280, Bot, I.,et al, 2013 Leptomeningeal Metastases in the MRI Era Neurol 74:1449-1454, Clarke,J.L., et al, 2010 Natalizumab: A Double-Edged Sword? Ann Neurol 66:262-263, DeAngelis,L., 2009 Chronic Inflammatory Demyelinating Polyneuropathy Associated with Malignant Melanoma Neurol 46:822-824, Bird,S.J.,et al, 1996 Occurrence of Different Cancers in Patients with Parkinson's Disease BMJ 310:1500-1501, Moller,H.,et al, 1995 Showing articles 0 to 12 of 12